Two recent studies analyzed treatment of diabetic macular edema with drugs that block vascular endothelial growth factor.
In the past month, a new meta-analysis compared metformin to other diabetes drugs, and the FDA expanded metformin's indications in patients with reduced kidney function.
Several factors that increase or decrease one's risk of developing diabetes were identified by research released this month.
Two recent studies and FDA approval of the first “artificial pancreas” highlight new technological advances in type 1 diabetes care.
The differences in outcomes between men and women with diabetes were the focus of a scientific statement from the American Heart Association and a study from Diabetologia, both published this month.
Three studies published in December looked at hypoglycemia, focusing on rates of severe hypoglycemia in the U.S., patients at high risk for hypoglycemia, and potential use of intranasal glucagon to treat the condition.
Technological advances that could improve diabetes control in the future made the news in the past month.
The prevalence and treatment of diabetes complications affecting the eye were analyzed by multiple studies published in the past month.
The American Association of Clinical Endocrinologists and the American College of Endocrinology updated their algorithm for treatment of type 2 diabetes, while the American Diabetes Association released a position statement on management of diabetes
World Diabetes Day is to be held on Nov. 14 and President Obama recently proclaimed November to be National Diabetes Month.